Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 794

1.
2.

Demethylation of the synuclein gamma gene CpG island in primary gastric cancers and gastric cancer cell lines.

Yanagawa N, Tamura G, Honda T, Endoh M, Nishizuka S, Motoyama T.

Clin Cancer Res. 2004 Apr 1;10(7):2447-51.

3.

The role of CpG islands hypomethylation and abnormal expression of neuronal protein synuclein-gamma (SNCG) in ovarian cancer.

Czekierdowski A, Czekierdowska S, Wielgos M, Smolen A, Kaminski P, Kotarski J.

Neuro Endocrinol Lett. 2006 Jun;27(3):381-6.

PMID:
16816827
4.

Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.

Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC Jr, Yu Y.

Cancer Res. 2003 Jul 15;63(14):4174-80.

6.

Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.

Sidiropoulos M, Pampalakis G, Sotiropoulou G, Katsaros D, Diamandis EP.

Tumour Biol. 2005 Nov-Dec;26(6):324-36. Epub 2005 Oct 26.

PMID:
16254462
7.
8.

Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers.

Liu H, Liu W, Wu Y, Zhou Y, Xue R, Luo C, Wang L, Zhao W, Jiang JD, Liu J.

Cancer Res. 2005 Sep 1;65(17):7635-43.

9.

Abnormal activation of the synuclein-gamma gene in hepatocellular carcinomas by epigenetic alteration.

Zhao W, Liu H, Liu W, Wu Y, Chen W, Jiang B, Zhou Y, Xue R, Luo C, Wang L, Jiang JD, Liu J.

Int J Oncol. 2006 May;28(5):1081-8.

PMID:
16596223
10.

Relationship of SNCG, S100A4, S100A9 and LCN2 gene expression and DNA methylation in bladder cancer.

Dokun OY, Florl AR, Seifert HH, Wolff I, Schulz WA.

Int J Cancer. 2008 Dec 15;123(12):2798-807. doi: 10.1002/ijc.23893.

11.

Epigenetic and genetic alterations of p33ING1b in ovarian cancer.

Shen DH, Chan KY, Khoo US, Ngan HY, Xue WC, Chiu PM, Ip P, Cheung AN.

Carcinogenesis. 2005 Apr;26(4):855-63. Epub 2005 Jan 27.

12.

Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5'-untranslated region in human epithelial ovarian carcinoma.

Suzuki F, Akahira J, Miura I, Suzuki T, Ito K, Hayashi S, Sasano H, Yaegashi N.

Cancer Sci. 2008 Dec;99(12):2365-72. doi: 10.1111/j.1349-7006.2008.00988.x. Epub 2008 Nov 17.

13.

Transcriptional suppression of synuclein gamma (SNCG) expression in human breast cancer cells by the growth inhibitory cytokine oncostatin M.

Liu J, Spence MJ, Zhang YL, Jiang Y, Liu YE, Shi YE.

Breast Cancer Res Treat. 2000 Jul;62(2):99-107.

PMID:
11016747
14.
15.

Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.

Strathdee G, Davies BR, Vass JK, Siddiqui N, Brown R.

Carcinogenesis. 2004 May;25(5):693-701. Epub 2004 Jan 16.

16.

5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer.

Zöchbauer-Müller S, Fong KM, Maitra A, Lam S, Geradts J, Ashfaq R, Virmani AK, Milchgrub S, Gazdar AF, Minna JD.

Cancer Res. 2001 May 1;61(9):3581-5.

17.

Frequent inactivation of hSRBC in ovarian cancers by promoter CpG island hypermethylation.

Tong SY, Ki KD, Lee JM, Kang MJ, Ha TK, Chung SI, Chi SG, Lee SK.

Acta Obstet Gynecol Scand. 2010 May;89(5):629-35. doi: 10.3109/00016341003678443.

PMID:
20423276
18.

Methylation of the 5' CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas.

Tanaka H, Shimada Y, Harada H, Shinoda M, Hatooka S, Imamura M, Ishizaki K.

Cancer Res. 1998 Aug 1;58(15):3429-34.

19.

Tumour specific promoter region methylation of the human homologue of the Drosophila Roundabout gene DUTT1 (ROBO1) in human cancers.

Dallol A, Forgacs E, Martinez A, Sekido Y, Walker R, Kishida T, Rabbitts P, Maher ER, Minna JD, Latif F.

Oncogene. 2002 May 2;21(19):3020-8.

20.

DNA methylation-dependent silencing of CST6 in human breast cancer cell lines.

Rivenbark AG, Jones WD, Coleman WB.

Lab Invest. 2006 Dec;86(12):1233-42. Epub 2006 Oct 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk